Incretin-based diabetes drugs don’t raise heart failure risk

Incretin-based antidiabetic drugs didn’t raise the risk of hospitalization for heart failure in an international observational study involving 1.5 million patients reported online March 24 in the New...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news